PaulDBrownMD

Radiation Oncology • Rochester, MN

Benign Diseases, Central Nervous System Cancer, Skin Cancer

Professor

Join to view full profile

Dr. Brown is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Brown's full profile

Already have an account?

Office
200 1st St SW
# Mayo
Rochester, MN 55905
Phone+1 507-284-2511

Summary

Dr. Paul Brown is a radiation oncologist in Rochester, MN and is affiliated with Mayo Clinic Hospital - Rochester. He has been in practice 19 years. He specializes in brain metastases and benign diseases and is experienced in primary brain tumors.

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Residency, Radiation Oncology, 1996 - 2000
Mayo Clinic College of Medicine and Science (Rochester)Internship, Internal Medicine, 1995 - 1996
University of North Dakota School of Medicine and Health SciencesClass of 1995

Certifications & Licensure

MT State Medical License 2020 - 2026
MN State Medical License 1996 - 2025
TX State Medical License 2010 - 2025
WY State Medical License 1999 - 2025
MI State Medical License 2020 - 2023
WI State Medical License 2004 - 2013
FL State Medical License 2001 - 2011
American Board of Radiology Radiation Oncology

Clinical Trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System Start of enrollment: 2004 Jan 01
Terminated
Phase 2
Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 2006 May 01
Completed
Phase 1
Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases Start of enrollment: 2006 Jul 01
Completed
Phase 3
Evaluation of Single Session Stereotactic Body Radiotherapy Start of enrollment: 2005 Oct 01
Active, not recruiting
Phase 1, Phase 2
Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS) Start of enrollment: 2002 Oct 25
Active, not recruiting
Phase 1, Phase 2
Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2009 Mar 01
Completed
Phase 1, Phase 2
Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors Start of enrollment: 2008 Mar 01
Completed
Phase 3
Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies Start of enrollment: 2006 Nov 01
Completed
High Dose Intensity Modulated Proton Radiation Treatment +/- Surgical Resection of Sarcomas of the Spine, Sacrum and Base of Skull Start of enrollment: 2012 Dec 01
Active, not recruiting
Not Applicable
Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery Start of enrollment: 2011 Jul 01
Completed
Phase 3
A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy Start of enrollment: 2012 Jun 18
Completed
Not Applicable
Glioblastoma Multiforme (GBM) Proton vs. Intensity Modulated Radiotherapy (IMRT) Start of enrollment: 2013 May 17
Completed
Phase 2
Single Fraction Stereotactic Radiosurgery Compared With Fractionated Stereotactic Radiosurgery in Treating Patients With Resected Metastatic Brain Disease Start of enrollment: 2019 Oct 11
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

119 citations
Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases: The FIRE-SCLC Cohort Study.
Chad G. Rusthoven, Masaaki Yamamoto, Denise Bernhardt, Derek E. Smith, Dexiang Gao
JAMA Oncology. 2020-07-01
624 citations
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
Jan C. Buckner, Edward G. Shaw, Stephanie L. Pugh, Arnab Chakravarti, Mark R. Gilbert
The New England Journal of Medicine. 2016-04-06
88 citations
Outcome in adult low-grade glioma: the impact of prognostic factors and treatment
David Schiff, Paul D. Brown, Caterina Giannini
Neurology. 2007-09-25

Journal Articles

Brain Metastases: Fractionated Whole-Brain Radiotherapy
Paul Brown, MD, ScienceDirect
Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes
Mark R Gilbert, Kevin S Roof, Paul D Brown, Samuel T Chao, William A Hall, Terri S Armstrong, Minesh P Mehta, Benjamin Movsas, Jeffrey S Wefel, David G Brachman, Merid..., Neurosurgery

Press Mentions

Radiotherapy for Brain Metastases: ASTRO Updates GuidelinesJune 10th, 2022
New Guideline Provides Guidance on the Use of Radiation Therapy to Treat Patients with Brain MetastasesMay 10th, 2022
Avoiding Hippocampus in Brain RT May Help Preserve Cognitive FunctionAugust 13th, 2021
Join now to see all